Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Altered calcium signaling is linked to early-stage Alzheimer's pathology

Alzheimer's disease is known for its slow attack on neurons crucial to memory and cognition. But why are these particular neurons in aging brains so susceptible to the disease's ravages, while others remain resilient?

9 Apr 2021

Accelerated cellular aging in depressed individuals associated with increased mortality risk

Cells from healthy individuals with major depressive disorder were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of Walter Reed Army Institute of Research and University of California San Francisco scientists, in collaboration with others.

8 Apr 2021

Powerful algorithms can 'predict' the biological language of cancer and Alzheimer's

Powerful algorithms used by Netflix, Amazon and Facebook can 'predict' the biological language of cancer and neurodegenerative diseases like Alzheimer's, scientists have found.

8 Apr 2021

Study offers a promising blood test for depression, bipolar disorder

Worldwide, 1 in 4 people will suffer from a depressive episode in their lifetime. While current diagnosis and treatment approaches are largely trial and error, a breakthrough study by Indiana University School of Medicine researchers sheds new light on the biological basis of mood disorders, and offers a promising blood test aimed at a precision medicine approach to treatment.

8 Apr 2021

Memory and executive function symptoms are valuable for predicting CTE pathology, suggests study

Diagnosing Chronic Traumatic Encephalopathy (CTE) during life is crucial for developing therapies and for determining how common the disease is among individuals exposed to repetitive head impacts from contact sports, military service and physical violence.

7 Apr 2021

USF wins $44.4 million NIH grant to test whether computerized brain training can prevent dementia

The National Institutes of Health has awarded the University of South Florida total expected funds of $44.4 million over the next five years to study whether computerized brain training exercises can reduce the risk of mild cognitive impairment (MCI), and dementias like Alzheimer's disease, in older adults.

7 Apr 2021

Individuals with Major Depressive Disorder have accelerated cellular aging

Cells from individuals with Major Depressive Disorder (MDD) were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of UC San Francisco scientists, in collaboration with others.

7 Apr 2021

Study: Alzheimer's disease treatments could reduce the financial burden to U.S. state budgets

Alzheimer's disease treatments that slow progression of the disease could significantly reduce the financial burden to U.S. state budgets, according to a new USC study.

5 Apr 2021

First-of-its-kind study identifies 13 new Alzheimer’s disease genes

In the first study to use whole genome sequencing (WGS) to discover rare genomic variants associated with Alzheimer's disease (AD), researchers have identified 13 such variants (or mutations).

3 Apr 2021

Study uncovers novel mechanism in rare mutation associated with Alzheimer's

A novel mechanism has been identified that might explain why a rare mutation is associated with familial Alzheimer's disease in a new study by investigators at the University of Chicago.

3 Apr 2021

50-state analysis finds excess deaths from COVID-19 and other causes in the U.S.

Extended surges in the South and West in the summer and early winter of 2020 resulted in regional increases in excess death rates, both from COVID-19 and from other causes, a 50-state analysis of excess death trends has found.

3 Apr 2021

Diet and lifestyle may play a significant role in Alzheimer's disease

For years, research to pin down the underlying cause of Alzheimer's Disease has been focused on plaque found to be building up in the brain in AD patients.

2 Apr 2021

Researchers develop new AI-based strategy to assess beef freshness

Although beef is one of the most consumed foods around the world, eating it when it's past its prime is not only unsavory, but also poses some serious health risks.

1 Apr 2021

Study reveals reason behind high risk of leukemia in children with Down syndrome

Children with Down syndrome are 20-times more likely to develop acute lymphocytic leukemia (ALL) and 150-times more likely to develop acute myeloid leukemia (AML) compared to their typical peers.

31 Mar 2021

COVID-19 patients with dementia have higher risk for complications, mortality

Early in the pandemic, neurologists expressed concern that COVID-19 patients with dementia may be at higher risk for complications and mortality.

31 Mar 2021

GlyNAC could improve many age-associated defects in older humans

A pilot human clinical trial conducted by researchers at Baylor College of Medicine reveals that supplementation with GlyNAC - a combination of glycine and N-acetylcysteine as precursors of the natural antioxidant glutathione - could improve many age-associated defects in older humans to improve muscle strength and cognition, and promote healthy aging.

29 Mar 2021

Alzheimer's Disease News and Research

Further Reading

Altered calcium signaling is linked to early-stage Alzheimer's pathology

Accelerated cellular aging in depressed individuals associated with increased mortality risk

Powerful algorithms can 'predict' the biological language of cancer and Alzheimer's

Study offers a promising blood test for depression, bipolar disorder

Memory and executive function symptoms are valuable for predicting CTE pathology, suggests study

USF wins $44.4 million NIH grant to test whether computerized brain training can prevent dementia

Individuals with Major Depressive Disorder have accelerated cellular aging

Study: Alzheimer's disease treatments could reduce the financial burden to U.S. state budgets

First-of-its-kind study identifies 13 new Alzheimer’s disease genes

Study uncovers novel mechanism in rare mutation associated with Alzheimer's

50-state analysis finds excess deaths from COVID-19 and other causes in the U.S.

Diet and lifestyle may play a significant role in Alzheimer's disease

Researchers develop new AI-based strategy to assess beef freshness

Study reveals reason behind high risk of leukemia in children with Down syndrome

COVID-19 patients with dementia have higher risk for complications, mortality

GlyNAC could improve many age-associated defects in older humans

Mimicking stress signals can protect the brain and retina from aging

Major CIHR grant to help find and tackle the root cause of neurodegenerative disease

Research sheds light on a new neuroprotective mechanism to control damage following brain injury

Newly identified pathway controls dangerous overreactions in the body's immune system

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News